A sensitivity analysis approach for informative dropout using shared parameter models. by Su, Li et al.
Biometrics 000, 000–000 DOI: 000
000 0000
A Sensitivity Analysis Approach for Informative Dropout using Shared
Parameter Models
Li Su1,∗, Qiuju Li1, Jessica K. Barrett1 and Michael J. Daniels2
1MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SR, U.K.
2Department of Statistics, University of Florida, Gainesville, FL 32611, U.S.A.
*email: li.su@mrc-bsu.cam.ac.uk
Summary: Shared parameter models (SPMs) are a useful approach to addressing bias from informative dropout in
longitudinal studies. In SPMs it is typically assumed that the longitudinal outcome process and the dropout time are
independent, given random effects and observed covariates. However, this conditional independence assumption is
unverifiable. Currently, sensitivity analysis strategies for this unverifiable assumption of SPMs are underdeveloped. In
principle, parameters that can and cannot be identified by the observed data should be clearly separated in sensitivity
analyses, and sensitivity parameters should not influence the model fit to the observed data. For SPMs this is difficult
because it is not clear how to separate the observed data likelihood from the distribution of the missing data given the
observed data (i.e., ‘extrapolation distribution’). In this paper, we propose a new approach for transparent sensitivity
analyses for informative dropout that separates the observed data likelihood and the extrapolation distribution,
using a typical SPM as a working model for the complete data generating mechanism. For this model, the default
extrapolation distribution is a skew-normal distribution (i.e., it is available in a closed form). We propose anchoring
the sensitivity analysis on the default extrapolation distribution under the specified SPM and calibrate the sensitivity
parameters using the observed data for subjects who drop out. The proposed approach is used to address informative
dropout in the HIV Epidemiology Research Study.
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1. Introduction
1.1 Shared parameter models and sensitivity analysis strategies
Shared parameter models (SPMs) are one of the three main model-based approaches to
dealing with informative dropout in longitudinal studies, where ‘informative’ means that the
dropout process depends on the unobserved outcomes even after conditioning on the observed
data (Tsiatis and Davidian, 2004; Daniels and Hogan, 2008). In SPMs the dependence
between the longitudinal outcome process and the dropout process is often characterized
by a set of time-invariant random effects. For example, a popular parameterization is to
specify simple random intercepts and random time slopes in the longitudinal outcome model,
while they are also included in the dropout model as covariates. Given the random effects
and observed covariates, it is typically assumed that the longitudinal outcome process (i.e.,
the complete longitudinal outcome data that are intended to be collected) and the dropout
time process are independent. This conditional independence assumption can be classified
as a latent ignorability assumption discussed in Harel and Schafer (2009). However, it is
unverifiable because it is not possible to assess the conditional independence between the
unobserved outcomes after dropout and the dropout time. Therefore, sensitivity analyses are
required for SPMs. In this paper we focus on the sensitivity of the inference for marginal
covariate effects on the longitudinal outcome to the unverifiable assumption of SPMs.
Unfortunately, unlike pattern mixture models (PMMs), research for sensitivity analysis
strategies based on SPMs is very limited. Sensitivity analyses, as defined in Daniels and
Hogan (2008), have been done for SPMs in a series of papers by Creemers and colleagues
(Creemers et al., 2010, 2011). Creemers et al. (2010) introduce a generalized class of SPMs
by incorporating additional random effects (not typically found in the original SPM) as
sensitivity parameters that connect the conditional distribution of the missing data given the
observed data (i.e., the extrapolation distribution) and the model for missingness indicators.
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The corresponding sensitivity parameters are not easily interpretable. Creemers et al. (2011)
also use the generalized class of SPMs with additional random effects, but their approach
is more similar to what we propose here because identifying restrictions like the missing
at random (MAR) assumption or the non-future dependence assumption (Kenward et al.,
2003) are used to define sub-classes of the generalized SPM that satisfy these restrictions.
However, in this paper we advocate using the typical SPM with the conditional independence
assumption and its default extrapolation distribution as the basis of a sensitivity analysis
(i.e., there are no additional random effects specified to link the the extrapolation distribution
and the dropout process) and introduce sensitivity parameters that are easily interpretable
in the context of the typical SPM.
Following the principle of a transparent sensitivity analysis advocated by Daniels and
Hogan (2008), we propose a new sensitivity analysis approach for informative dropout based
on a typical SPM with the conditional independence assumption, where the likelihood for
observed data and the sensitivity parameter are clearly separated. Within the Bayesian
framework, we first fit the SPM proposed by Barrett et al. (2015) to the observed longitudinal
outcome data and the dropout time. Specifically, a linear mixed model is assumed for
the complete longitudinal outcomes, while the dropout time distribution follows a probit
model for the discrete hazard of dropout. The two models are linked by correlated normal
random effects. Given these random effects and observed covariates, the longitudinal outcome
process and the dropout process are assumed to be independent. We show that under this
SPM, the default extrapolation distribution for missing data after dropout is a skew-normal
distribution depending on model parameters, covariates and observed longitudinal outcome
data. The proposed sensitivity analysis is then anchored at this ‘default’ extrapolation
distribution and a piece-wise linear model for individual longitudinal profiles is specified
to determine the extrapolation distribution at a fixed value of a global sensitivity parameter.
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The global sensitivity parameter can be interpreted as the parameter that controls the overall
deviation of the individual longitudinal profiles after dropout from the default extrapolations
under the SPM. Given a specific set of values for the covariates, posterior samples of the
model parameters and an informative prior for the global sensitivity parameter based on the
substantive context, we use G-computation (Robins, 1986; Scharfstein et al., 2014) to obtain
the inferences for the marginal (population-averaged) covariate effects on the longitudinal
outcome under both the default extrapolation distribution of the SPM and the extrapolation
distribution specified in the sensitivity analysis. The G-computation and the Markov Chain
Monte Carlo (MCMC) for fitting the SPM are separate; therefore our sensitivity analysis
approach does not impact the fit of the model to the observed data.
1.2 Motivating example
This work is motivated by data from the HIV Epidemiology Research Study (HERS). The
HERS was a longitudinal study of 1310 women with, or at high risk for, HIV infection
from 1993 to 2000 (Smith et al., 2003). During the study 12 visits were scheduled, where a
variety of clinical, behavioral and sociological outcomes were recorded approximately every
6 months. We will focus on the 850 women who were HIV-positive and had CD4 count
measurements at enrollment.
Like many other long-term follow-up studies, attrition by dropout in the HERS is substan-
tial, with more than half of the women not completing the study. Moreover, as suggested
by previous analyses of these data (Hogan et al., 2004; Daniels and Hogan, 2008), dropout
was likely informative and related to the disease progression characterized by CD4 counts.
In other words, the unobserved CD4 counts among those who dropped out could be system-
atically lower than those who continued follow-up, even after adjusting for covariates and
observed CD4 counts. Hogan et al. (2004) adopted the pattern mixture modeling approach
to dealing with this informative dropout problem when estimating the marginal effects of
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baseline covariates (HIV viral load, HIV symptom severity, antiretroviral treatment status)
on the longitudinal CD4 count for the HERS data. In this paper, we choose the shared
parameter modeling approach for the HERS data and implement the proposed sensitivity
analysis strategy tailored to SPMs. Because HIV disease progression, represented by changes
in CD4 count, is believed to be strongly associated with the dropout, we use random effects
in the model for CD4 counts to characterize the HIV disease progression. These random
effects also govern the relationship between HIV disease progression and dropout.
The rest of the paper is organized as follows. In Section 2, we describe the proposed
sensitivity analysis strategy, show its implementation using the specified SPM and derive
the default extrapolation distribution for the missing outcome under this SPM. In Section
3, the HERS data are analyzed to illustrate the proposed methods. We conclude with a
discussion in Section 4.
2. Methods
2.1 Sensitivity Analysis Strategy
In this section, we propose a general sensitivity analysis strategy for informative dropout
using SPMs. Because random effects are often used to characterize the individual longi-
tudinal profile, we can interpret the default extrapolation under a SPM as trying to use
the same random effect distribution given observed data before dropout for characterizing
the individual longitudinal profile after dropout. However, this might not be true if this
individual longitudinal profile beyond dropout varies from what the SPM predicts under the
conditional independence assumption. For example, in the HERS example, it is plausible
that the unobserved CD4 counts after patients’ dropout were decreasing more rapidly than
the SPM predicts. Therefore the individual longitudinal profile after dropout might not be
able to be described by the conditional distribution of the random effects given all observed
data. This discrepancy cannot be identified from the observed data, and can be the basis for
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a sensitivity analysis. Figure 1 provides a graphical illustration for the default extrapolation
under a SPM and the possible extrapolation under our proposed sensitivity analysis strategy.
[Figure 1 about here.]
We propose to anchor the sensitivity analysis at the default extrapolation distribution of
the SPM. In the next sections, we describe a typical SPM in our approach and the details
of the sensitivity analysis strategy for it.
2.2 Model
Suppose that N independent patients are followed up over time. For the ith (i = 1, . . . , N)
patient, longitudinal measurements Yi = (Yi1, . . . , YiM)
T are scheduled to be taken at time
points ti1, . . . , tiM in [0, T ], where T is the total length of scheduled follow-up in the study.
However, patient can withdraw from the study during the follow-up, which terminates the
observation of the longitudinal outcome Yi. Let Si denote the ‘dropout time’ for the ith
patient. Information about exact time of dropout is often not available in practice. Therefore,
we define Si to be the number of the last follow-up visit, and hence it is discrete. When
Si = j − 1 < M (j = 2, . . . ,M), the outcome vector (Yij, . . . , YiM)T are unobserved. If the
patient has complete data, then Si is treated as administratively censored at visit M . We
let Yoi = (Yi1, . . . , Yi,j−1)
T denote the vector of the observed outcomes and assume that Yi1
is always observed (baseline outcome).
In this paper, we adopt the SPM in Barrett et al. (2015) that is well suited to the HERS





ijbi + εij, (1)
where β is a p× 1 vector of regression coefficients associated with exogenous covariates xij
(fixed effects), bi is a q×1 vector of random effects that are associated with covariates zij, εij
is the measurement error that is independent of covariates xij and zij, and (εi1, . . . , εiM)
T ∼
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N(0, σ2ε IM×M). The covariate vectors xij and zij are assumed to be completely observed. In
the HERS application, we assume xij includes (1, tij)
T and baseline covariates; and zij =
(1, tij)
T, so bi corresponds to a random intercept and a random slope. The random effects
bi follow a multivariate normal distribution N(0,Σb).
Let λi,j−1 = P(Si = j−1 | Si > j−1,bi,xS,i,j−1,Wi,j−1) be the discrete hazard of dropout
at visit j − 1 (j = 2, . . . ,M). We assume a probit model,






where Φ(·) is the standard normal cumulative distribution function, xS,i,j−1 is a pS×1 vector
of covariates (possibly time-varying) with regression coefficients α. Wi,j−1 is a matrix for
constructing a qS × 1 vector of linear combinations of bi. In the HERS application, we have
Wi,j−1 = I2×2 and qS = 2. Other examples of Wi,j−1 include (1, ti,j−1)
T; see discussion on
these parameterizations in Chapter 7 of Rizopoulos (2012). γj−1 is an association parameter
vector that relates the longitudinal outcome and the dropout time via the random effects
bi. Note that if γj−1 = 0 then the dropout is ignorable. Given bi and the covariates, the
complete longitudinal outcome Yi and the dropout time Si are assumed to be independent.
2.3 Estimation and inference
We use a Bayesian approach for estimation and inference of the SPM. For simplicity of
presentation we suppress the conditioning on xij, zij, xS,i,j−1 and Wi,j−1. The observed data
are {Yoi , Si = j − 1} (i = 1, . . . , N), and the observed data likelihood contribution from the
ith patient given the random effects is
Li(θ | Yoi , Si = j − 1,bi) = f(Yoi | bi;θ)f(Si = j − 1 | bi;θ)f(bi;θ), (3)
where θ denotes all unknown parameters in the SPM that include regression coefficients β,
α, γj−1 and covariance parameters in Σb. Let Xi = (xi1, . . . ,xiSi)
T and Zi = (zi1, . . . , ziSi)
T.
The likelihood from the observed longitudinal outcome given the random effects is
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f(Yoi | bi;θ) = exp
{
− log(2π)Si/2− log(|Vi|)/2− (Yoi − µi)TV−1i (Yoi − µi)/2
}
,
where µi = Xiβ + Zibi and Vi = σ
2
ε ISi×Si . The observed data likelihood contribution from
the dropout time given the random effects is
f(Si = j − 1 | bi;θ) =

λi1 when j − 1 = 1
λi,j−1
∏j−2
l=1 (1− λil) when 1 < j − 1 < M∏j−2
l=1 (1− λil) when j − 1 = M
(4)
Recall the density f(bi;θ) is N(0,Σb). We follow Daniels and Zhao (2003) and use the
modified Cholesky decomposition to parameterize Σb such that positive definiteness is guar-
anteed for Σb. In the HERS analysis in Section 3, we assume bi = (bi1, bi2)
T, where bi1 is a
random intercept and bi2 is a random slope. Then bi can be written in two parts: bi1 = ei1,
bi2 = δbi1 + ei2. The first equation corresponds to the marginal distribution of the random
intercept, and the second equation describes the conditional distribution of the random slope
given the random intercept. Let σ21 and σ
2
2 be the variances of ei1 and ei2, respectively. Then








We provide details of the prior specification and posterior inference in the context of the
HERS analysis in Section 3.
2.4 Default extrapolation distribution under the SPM
To derive the default extrapolation distribution of the missing outcome Yik (k = j, . . . ,M)
after dropout at visit j−1, we first need to derive the conditional distribution of the random
effects bi, given the observed data Yi1, . . . , Yi,j−1, Si = j − 1, and Hi,j−1. Here Hi,j−1 is the
collection of the history of the corresponding covariates xi,j−1, zi,j−1, xS,i,j−1, Wi,j−1 up to
visit j − 1 (an overbar represents the history of a process). The conditional density of bi
8 Biometrics, 000 0000
given the observed data is
f(bi | Yi1, . . . , Yi,j−1, Si = j − 1,Hi,j−1) (5)




This conditional density is a member of the class of multivariate skew-normal distribution
described in González-Faŕıas et al. (2004) and Arnold (2009). Details of the proof for this
distribution can be found in supporting information.
Recall that the missing outcome Yik (k = j, . . . ,M) after dropping out at visit j − 1 is




ikbi + εik in (1) with
the error term assumed to be independent of the random effects and covariates. Given the
additive property of the multivariate skew-normal distribution (González-Faŕıas et al., 2004),
the conditional distribution of Yik given the observed data, Yi1, . . . , Yi,j−1, Si, Hik, xik and zik,
can also be shown to follow a skew-normal distribution; see details in supporting information.
This conditional distribution for Yik is the default extrapolation distribution under the
specified SPM. Given the model parameters and covariates, sampling from this extrapolation
distribution can proceed by separately drawing from the conditional distribution of bi given





2.5 Sensitivity analysis for the SPM
Without loss of generality, we let zik = (1, tik)
T and then bi = (bi1, bi2)
T represents the
random intercept and random slope. In the sensitivity analysis, the model for Yik (k =
j, . . . ,M) after dropout at visit j − 1 is assumed to follow a piece-wise linear model
Yik = x
T
ikβ + bi1 + bi2tik + ∆i(tik − ti,j−1)+ + εik, (6)
where (x)+ = x if x > 0 and 0 otherwise. Note that (bi1, bi2)
T in (6) follows the distribution
in (5). ∆i is the change of the slope for the ith patient after dropout at visit j − 1 (i.e.,
deviation from the random slope bi2; see Figure 1), which can depend on the observed data
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of the ith patient; when ∆i = 0 for all i we obtain the default extrapolation distribution.
For example, let
∆i = a {(M − Si)/(M − 1)}σbi2 , (7)
where a is the sensitivity parameter and σbi2 = {Var(bi2 | Yi1, . . . , Yi,j−1, Si = j−1,Hi,j−1)}1/2
is the standard deviation of the random slope given the observed data of the ith patient.
When Si = M , the patient has complete data, therefore no adjustment for the slope bi2 is
made and ∆i = 0. ∆i is proportional to (M − Si)/(M − 1), which allows more adjustment
of the random slope made for earlier dropout because these patients might have more severe
disease progression than what is characterized by the random effects. In particular, when
Si = 1 and the patient drops out right after baseline, the adjustment is the largest with
∆i = aσbi2 , i.e., a times standard deviation of the random slope given the observed data of
the ith patient. If Si = M −1 and the patient almost completes the study except for the last
scheduled visit, the adjustment is only a/(M − 1) times standard deviation of the random
slope given the observed data. We specify ∆i to be proportional to σbi2 to allow for the
adjustment calibrated to the observed outcome variation given the individual characteristics
of a specific patient. Note that ∆i implicitly depends on the covariates because σbi2 is the
posterior standard deviation of the random slope conditional on all observed data (including
the covariates). Therefore, implicitly the approach allows interactions between ∆i and the
covariates. Finally, a is a single sensitivity parameter that controls the overall deviation of
the individual longitudinal profiles after dropout from the default extrapolations under the
SPM for the study sub-population with dropout.
Within the Bayesian framework, we can specify a prior for a. For example, in the HERS
example in Section 3, we believe that patients can have more rapidly decreasing CD4 count
profiles after dropout, therefore a is assumed to follow a triangular distribution with the range
[−2, 0] and the mode at −1. Thus we expect at most a two-standard-deviation downward
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change for the slope for the earliest dropouts and overall the change is centered at one
standard deviation. When possible, the prior for the global sensitivity parameter a should
be elicited from expert opinion (or historical information).
Sampling from the extrapolation distribution in the sensitivity analysis requires calculation
of σbi2 . In supporting information, we show that this standard deviation is a function of the
model parameters and observed data. We then calculate ∆i in (7), given the sensitivity
parameter, and use the model in (6) to sample from the extrapolation distribution.
To assess the impact of the sensitivity parameter on the final inference, we use Monte
Carlo integration (i.e., G-computation) to calculate the predicted means of the longitudinal
outcome and summarize the marginal covariate effects on these predicted means for both
the fitted SPM and sensitivity analysis. Specifically, the steps are:
(1) Draw a sample from the prior for the sensitivity parameter a.
(2) Draw a sample of (Yi, Si) based on the specified SPM, a specific set of covariate values,
and a single set of posterior samples of the model parameters.
(3) Yi is truncated at Si to obtain the replicated observed longitudinal data vector Y
o
i .
(4) If Si < M , then sample the missing outcomes from the default extrapolation distribution
under the SPM and from the extrapolation distribution based on the model (6) and the
current sample of a.
(5) Repeat Steps 2-4 for 100N times. Note that the size of the Monte Carlo samples needs
to be large relative to the sample size N . Here we follow Linero and Daniels (2018) and
use 100 times the sample size.
(6) Calculate summaries of all longitudinal outcome samples, e.g., average changes of longi-
tudinal outcomes from baseline to specific follow-up visits.
(7) Repeat Steps 2-6 for other sets of covariate values and calculate baseline covariate effects
on the longitudinal data summaries in Step 6 using contrasts between covariate groups.
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(8) Repeat Steps 1-7 for the entire set of posterior samples of model parameters, and
summarize the posterior distribution of the baseline covariate effects obtained in Step 7.
3. Application to the HERS data
In this section, we implement the proposed approach to the HERS data. Of the 850 women
who were HIV-positive and had CD4 count data at baseline, we exclude 23 women from the
analysis because their baseline covariate data were missing. The dropout time is treated as
discrete and set as the number of the last follow-up visit. For those women who finished
12 scheduled visits, their dropout times are treated as administratively censored at visit
12. During the follow-up, 566 (7.6%) CD4 count measurements were intermittently missing
before the patients’ dropout or the end of study. We assume that this intermittent missingness
is latent ignorable (Harel and Schafer, 2009). That is, given the observed outcomes, random
effects, dropout time, and covariates, the intermittent missingness is ignorable.
3.1 Fitted model
Following the previous analysis of the HERS data (Hogan et al., 2004), we assume a linear
mixed model for the complete longitudinal measurements of CD4 count as follows,
Yij = x
T
ijβ + bi1 + bi2j
∗ + εij, (8)
where Yij is the square root of CD4 count at visit j after standardization by taking (y−18)/7
and xij is the covariate vector, including the visit j
∗ = (j − 1)/11, indicator variables for
HIV viral load group (0, 500], (500, 5000], (5000, 30000] (copies/ml) at baseline, indicator
of antiretroviral therapy (ART) at baseline, HIV symptomatology (presence of HIV-related
symptoms on a scale from 0-5) at baseline and the interactions between time (visit) and these
baseline covariates. bi1 and bi2 are random intercept and slope, respectively, and they follow
the multivariate normal distribution with mean zero and covariance Σb, as parameterized
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by the modified Cholesky decomposition. The error term follows εij
i.i.d.∼ N(0, σ2ε ), which is
independent of the random effects.
Based on some preliminary data exploration, we specify the following probit model for the
discrete hazard for the dropout time,
λi,j−1 = P(Si = j − 1|Si > j − 1,xS,i,j−1, bi1, bi2) = 1− Φ(xTS,i,j−1α + γ1bi1 + γ2bi2), (9)
where j − 1 = 1, . . . ,M − 1, the covariate vector xS,i,j−1 includes indicators of baseline
HIV viral load groups, HIV symptomatology at baseline, indicator of ART at baseline,
(j− 1)∗ = (j− 2)/11 and {(j− 1)∗}2 (to account for the change in the discrete-time hazards
over time), and the interaction between ART and time (j − 1)∗. The specification of the
functional forms of the random effects in (9) is based on the belief that patients who had
higher CD4 count levels at baseline (i.e. intercept) and/or who showed a lower decreasing
rate in their longitudinal CD4 count profiles (i.e. time slopes) are less likely to drop out.
3.2 Priors and posterior inference
Independent normal priors N(0, 100) are assigned to β and the parameter δ in Σb. For
parameters in (9), we assign weakly informative N(0, 4) priors to α, γ1 and γ2. For variance
component parameters, we assign the prior σ2ε ∼ Inverse-Gamma(0.001, 0.001) and σk ∼
Uniform(0, 5) (k = 1, 2) for Σb. We run three MCMC chains with diverse initial values using
the WinBUGS package (Spiegelhalter et al., 2003) and assess convergence within a 5, 000-
iteration burn-in period using trace plots and Gelman and Rubin convergence statistics. The
computation time is about 3.5 hours on a Windows server with 2.60GHz CPU (4 processors)
and 128GB memory when parallelizing the chains, which can be reduced if using MultiBUGS
(Goudie et al., 2017), the newly released parallelized version of WinBUGS. After convergence,
pooled posterior samples of size 9000 (after thinning by 5) are used for model inference.
Sensitivity analysis using SPMs 13
3.3 Model assessment
To assess the fit of the SPM to the observed data, we use posterior predictive checks,
specifically the χ2 discrepancy statistics described in Gelman et al. (1996) with replicated
observed data, as recommended in Daniels et al. (2012) and Xu et al. (2016). Detailed steps
can be found in supporting information. The posterior probability that the χ2 statistic is
larger than the observed χ2 statistic is 0.212, which does not indicate lack of fit of our SPM
to the observed HERS data.
3.4 Posterior Inference
The posterior summaries for the parameters in the SPM are presented in Table 1. For
comparison, we also fit a linear mixed model (LMM) that has the same form as in (8)
but assumes ignorability of the dropout time and a PMM that was described in Hogan et al.
(2004). Details for the PMM can be found in supporting information.
[Table 1 about here.]
The estimated main effect of time (posterior mean) from the SPM is -1.21 (95% credible
interval (CI) =[-1.59,-0.84]), which is larger in magnitude than the estimate from the LMM
under the ignorability assumption. The primary difference between the LMM and SPM
analyses is that the LMM assumes that those who dropped out from the study had similar
longitudinal CD4 profiles (intercept and time slopes) as those that did not, given past
observed longitudinal data and covariates. However, from Table 1 it is clear that patients
who dropped out early tended to have larger declines in CD4 count over time (γ2 = 0.28
(95% CI =[0.22, 0.35])). As a result, the time slope under ignorability may be underestimated
(with less steep decline). Similarly, the SPM estimates show larger differences in the slope of
CD4 count within baseline viral load groups, while results for the dropout model in Table 1
indicate that the hazard of dropout is higher for those with higher baseline HIV viral load.
Nevertheless, due to the unverifiable assumption on the extrapolation distribution in the
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SPM, it is essential to conduct sensitivity analysis to check the impact on the final inference
for the covariate effects in the HERS population.
3.5 Sensitivity analysis
For sensitivity analysis, we use the specification for ∆i as in (7) and assume that the sensitiv-
ity parameter a follows a triangular distribution with the range [−2, 0] and the mode at −1.
Because we standardized the visit number j in (8), the missing outcome Yik (k = j, . . . , 12) af-
ter dropout at visit j−1 has the following form, Yik = xTikβ+bi1+bi2k∗+∆i{k∗−(j−1)∗}++εik,
where ∗ stands for standardization by taking (x − 1)/11. Sampling from this distribution
then follows the procedure as described in Section 2.5.
To summarize the covariate effects, we use the G-computation procedure described in
Section 2.5. For presentation purpose, we fix the value of baseline HIV symptoms at zero
and focus on the effects of baseline HIV viral load and ART treatment groups.
Sampling from the extrapolation distribution in the sensitivity analysis involves evaluating
the posterior standard deviation of the random slope given the observed data, σbi2 , for each
G-computation sample. In supporting information, it can be seen that these evaluations
require numerous calculations of multivariate normal probabilities, which slow down the
overall G-computation when the dimension of the multivariate normal is high (up to 11 in
the HERS example). To speed up the G-computation for the HERS analysis, we approximate
σbi2 using the average estimated posterior standard deviations of the random slopes for all
HERS patients within each of the 8 covariate groups defined by the baseline viral load level,
ART status and HIV symptoms. More details about the approximation of σbi2 can be found
in supporting information. We use n = 82700 Monte Carlo samples for each covariate group
given a set of posterior samples of model parameters. The G-computation is parallelized for
320 sets of posterior samples of the model parameters using the ‘parallel’ package in R on
high performance clusters. It takes less than 2 hours to finish the G-computation for a set of
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posterior samples. This can be further reduced if the Monte Carlo samples for each posterior
sample are divided into blocks for parallelization.
Note that the marginal covariate effects in the sensitivity analysis no longer follow a linear
form as in the fitted SPM, i.e., there are interactions between covariates. Therefore we provide
the effects of baseline viral load level given the ART status, and also the effects of ART status
given the baseline viral load level, on the changes of mean CD4 counts from baseline to visits
6 and 12 in Figure 2. The top of Figure 2 shows the differences of the mean CD4 count
changes between three baseline viral load groups and the reference group (> 30000), given
the ART status. The estimated viral load effects in the sensitivity analysis are all larger
than those in the SPM. This is because the mean CD4 counts are adjusted downwards in
the sensitivity analysis compared with the SPM estimates, and the adjustment is biggest for
the group with highest viral load (reference group) which was more likely to drop out. As
a result, conclusions about the viral load effects differ in the two analyses. For example, in
both analyses the viral load (5000, 30000] group is associated with smaller decreases in mean
CD4 counts from baseline to visits 6 and 12, compared with the highest viral load group.
But in the sensitivity analysis, the 95% CIs for these effects no longer cover zero, unlike in
the SPM. Similarly, conclusions about the effects of the ART status also differ between the
two analyses. For example, the effects of the ART status (the bottom of Figure 2) have been
reduced in the sensitivity analysis, in particular, the 95% CIs for the ART effects in the
higher viral load groups ((5000, 30000], > 30000), now cover zero.
Overall, despite these differences, it appears that the conclusions of the covariate effects
from the SPM are not overly sensitive to the deviations considered here. For example, given
other baseline covariates, patients with higher baseline viral load had larger decreases of mean
CD4 counts compared with patients with lower baseline viral load. This is also consistent
with the findings from the PMM; see details in supporting information.
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[Figure 2 about here.]
4. Conclusion and discussion
In this paper we proposed a new sensitivity analysis approach for informative dropout using
SPMs. The distinctive feature of our approach is that the inference for observed data is not
influenced by the global sensitivity parameter, which follows the principle as proposed by
Daniels and Hogan (2008) in a full probability model based setting. We showed that the
default extrapolation distribution under the SPM specified here is available in a closed form.
Therefore it is convenient to anchor our sensitivity analysis at this default extrapolation
distribution. In addition, using the HERS data, we demonstrated that the deviation of
the extrapolation distribution specified in the sensitivity analysis from the default can be
calibrated using the observed data for each patient who dropped out.
Sensitivity analysis approaches for informative dropout based on selection models and
PMMs have also been proposed in the literature. In selection models, the sensitivity parame-
ter is specified in the selection function (e.g., the regression coefficients in the dropout model).
However, with parametric models for the longitudinal outcome and the selection function,
altering the sensitivity parameter in the selection function will also affect the model fit to
the observed data, which is not consistent with the principle of sensitivity analyses (Daniels
and Hogan, 2008). Since SPMs are also parametric, we anchor our sensitivity analysis at the
extrapolation distribution of the missing outcomes, not at the selection function, similarly
to the sensitivity analysis approach based on PMMs. We provide a more detailed discussion
on sensitivity analysis based on PMMs in supporting information.
Because we specified a piece-wise linear model for the individual longitudinal profile and
the random intercept bi1 reflects the CD4 count level at baseline of the HERS where data
are complete, we did not connect bi1 to the sensitivity parameter. However, if we follow the
approach in Linero and Daniels (2015), we can specify the sensitivity parameter to represent
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a location shift from bi1 + bi2t, where t is a time point after dropout. This location-shift
model can also be used in a SPM with informative intermittent missing data, where the
series of missing data indicators are modeled using a probit model. It is straightforward to
show that the default extrapolation distribution under this SPM is also skew-normal that
depends on all observed outcome data (not only the observed outcome data up to the current
visit with the intermittent missing data), covariates, and model parameters. The sensitivity
analysis can again be anchored at this default extrapolation distribution and we then specify
a location shift model for the deviation from the default extrapolation distribution that is
again controlled by a global sensitivity parameter. The final inference under the SPM and
sensitivity analysis can be provided through G-computation.
Using a probit model for the discrete hazard of dropout, the SPM used in our approach
benefits from a closed form of the default extrapolation distribution. The probit link used
in the dropout model not only facilitates sensitivity analysis, but also naturally reflects
the assumption that the discrete hazard of dropout depends on the normally distributed
random effects that characterize underlying individual longitudinal profiles. Other models,
e.g., logistic models, can also be used in a SPM. However, in such models, the default
extrapolation distributions are not available in closed forms. To approximate them, we can
first sample the posterior distribution of the random effects using the Metropolis-Hastings
algorithm and then sample the missing outcomes using the longitudinal model specified in
the SPM and the samples of random effects and other model parameters. This is similar to
the algorithm used for dynamic predictions based on SPMs described in Rizopoulos (2011).
The general approach for sensitivity analysis proposed here is similar in spirit to the
framework proposed by Linero and Daniels (2015) and Linero (2017), where a flexible
‘working model’ for the joint distribution of the complete longitudinal outcomes and the
dropout time is specified and identifying restrictions are then applied when performing
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sensitivity analyses with the extrapolation distribution. The typical SPM can be thought of
as the ‘working model’ described in these papers. Here, however, we recommend performing
sensitivity analysis grounded off the extrapolation distribution from the ‘working model’,
unlike anchoring at the MAR restrictions as done in Linero and Daniels (2015) and Linero
(2017).
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Visit 
Dropout time Study end  
Default extrapolation 
Extrapolation under sensitivity analysis 
Outcome 
Observed data  
Figure 1. Graphical illustration of the default extrapolation under a typical SPM and the
possible extrapolation under the proposed sensitivity analysis.
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Visit 6
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Figure 2. Results (posterior means and 95% credible intervals) for marginal covariate
effects on changes of mean square root CD4 counts from baseline to visits 6 and 12 in the
HERS analysis. Top: baseline viral load effects on mean CD4 count changes, given baseline
ART status. Bottom: baseline ART status effects on mean CD4 count changes, given baseline
viral load levels. Solid lines ( ): 95% credible intervals under the default extrapolation
distribution of the SPM; dashed lines ( ): 95% credible intervals under the extrapolation
distribution in the sensitivity analysis. The estimated effects with 95% credible intervals
covering zero and not covering zero are in gray and black, respectively.
Sensitivity analysis using SPMs 23
Table 1




Mean 2.5% 97.5% Mean 2.5% 97.5% Mean 2.5% 97.5%
Intercept -0.55 -0.75 -0.36 1.11 0.91 1.32 -0.57 -0.75 -0.38
Baseline HIV viral load
0-500 1.52 1.32 1.74 0.75 0.54 0.97 1.54 1.33 1.74
500-5k 1.02 0.82 1.22 0.63 0.44 0.83 1.03 0.83 1.21
5k-30k 0.47 0.26 0.70 0.26 0.05 0.47 0.48 0.26 0.69
30k+ (reference)
Baseline HIV symptoms -0.02 -0.07 0.03 -0.01 -0.06 0.05 -0.03 -0.08 0.03
ART at baseline -0.65 -0.77 -0.53 -0.22 -0.40 -0.04 -0.66 -0.77 -0.55
(j − 1)∗ - - - 1.67 1.09 2.28 - - -
{(j − 1)∗}2 - - - -2.79 -3.41 -2.16 - - -
(j − 1)∗*ART at baseline - - - 0.37 0.04 0.70 - - -
Time (visit) -1.21 -1.59 -0.84 - - - -0.91 -1.29 -0.54
Time*baseline viral load
0-500 0.59 0.21 1.00 - - - 0.37 -0.03 0.78
500-5k 0.53 0.15 0.91 - - - 0.35 -0.03 0.74
5k-30k 0.37 -0.06 0.79 - - - 0.25 -0.16 0.67
30k+ (reference) - - -
Time*baseline HIV symptoms -0.06 -0.15 0.04 - - - -0.04 -0.14 0.05
Time*ART at baseline 0.21 0.01 0.40 - - - 0.25 0.06 0.43
corr(bi1, bi2) -0.20 -0.29 -0.13 - - - -0.23 -0.31 -0.14
var(bi1) 0.56 0.50 0.62 - - - 0.56 0.50 0.62
var(bi2) 1.24 1.07 1.44 - - - 1.12 0.97 1.29
σ2ε 0.15 0.14 0.16 - - - 0.15 0.14 0.16
γ1 - - - 0.23 0.15 0.30 - - -
γ2 - - - 0.28 0.22 0.35 - - -
